NYBC Ventures

President and CEO, New York Blood Center Enterprises (NYBCe); General Partner, NYBC Ventures; Distinguished Investigator, Lindsley F. Kimball Research Institute; and Professor, Department of Medicine, Weill Cornell College of Medicine.

Executive Vice President and Chief Business Officer, provides business development leadership and directs NYBCe’s cell manufacturing business unit, Comprehensive Cell Solutions®, as well as the Enterprise’s specialty pharmacy.

Leverages her expertise in venture capital and strategic investments to identify and support innovative companies, driving the firm’s investment strategy.

Since joining NYBC Ventures in 2024, Kuan has played an important role, identifying and assessing companies within NYBCV’s core focus areas.

Executive Vice President (EVP) and Chief Investment Officer of Brighthouse Financial, responsible for the overall management of the company’s investment portfolio.

Biotech executive, Board member, and advocate for patients, was chief business and strategy officer for Global Blood Therapeutics (GBT), a leader in sickle cell disease.

Organic and biochemist with over 30 years of experience in leading technology and product development programs in the pharmaceutical, biopharmaceutical, and drug delivery fields.

Biopharmaceutical leader with decades of experience in global drug development, new company formation and value creation in biotechnology, large pharma and venture capital.